Zynex, Inc. to Announce First Quarter 2023 Financial Results

Rhea-AI Summary

Zynex, a medical technology company listed under Nasdaq: ZYXI, has announced it will report its first-quarter financial results for 2023 on April 27, 2023. The report will include insights into their non-invasive medical devices for pain management and rehabilitation. Management will discuss the results during a conference call and webcast scheduled for 2:15 PM MT / 4:15 PM ET. Interested participants can register via the provided link or dial in.

Founded in 1996, Zynex specializes in developing and selling medical devices used in hospitals and patient care. The company emphasizes its forward-looking statements regarding future conditions and the inherent uncertainties involved.

Positive

• Scheduled release of first-quarter financial results on April 27, 2023.
• Opportunity for investors to gain insights during the conference call.

Negative

• Forward-looking statements highlight potential risks, including dependence on reimbursement from health insurance companies.
• Uncertainties mentioned regarding competition and need for CE marking of new products.

ENGLEWOOD, Colo., April 19, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report first quarter 2023 financial results on Thursday, April 27, 2023. Zynex's management will host a conference call and webcast at 2:15 p.m. MT / 4:15 p.m. ET that day to discuss the financial results and provide a corporate update.

Webcast Details: Thursday, April 27, 2023 at 2:15 p.m. MT / 4:15 p.m. ET

To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast: https://app.webinar.net/brLKVKJWPYk

US Participant Dial In (TOLL FREE): 1-844-825-9790 
International Participant Dial In: 1-412-317-5170 
Canada Participant Dial In (TOLL FREE): 1-855-669-9657

About Zynex, Inc. 
Zynex, founded in 1996, develops, manufacturers, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com

Safe Harbor Statement 
This release contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore you should not rely on any of these forward looking statements. The Company makes no express or implied representation or warranty as to the completeness of forward-looking statements or, in the case of projections, as to their attainability or the accuracy and completeness of the assumptions from which they are derived. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement for our products from health insurance companies, our dependence on third party manufacturers to produce our products on time and to our specifications, implementation of our sales strategy including a strong direct sales force, the impact of COVID-19 on the global economy and other risks described in our filings with the Securities and Exchange Commission including but not limited to, our Annual Report on Form 10-K for the year ended December 31, 2022 as well as our quarterly reports on Form 10-Q and current reports on Form 8-K.

Any forward-looking statement made by us in this release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contact: Zynex, Inc. (800) 495-6670

Investor Relations Contact: 
Gilmartin Group 
Investor Relations Counsel 
ir@zynex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-inc-to-announce-first-quarter-2023-financial-results-301801541.html

SOURCE Zynex

FAQ

When will Zynex report its first-quarter 2023 financial results?

Zynex will report its first-quarter 2023 financial results on April 27, 2023.

What time is Zynex's financial results webcast?

Zynex's financial results webcast is scheduled for 2:15 PM MT / 4:15 PM ET on April 27, 2023.

What is Zynex's stock symbol?

Zynex is listed under the stock symbol ZYXI.

How can I participate in the Zynex financial results conference call?

Participants can register and join the conference call via the provided link or by dialing in 10-15 minutes prior.